Abiopharma

News list

(99% Neutral) VERA THERAPEUTICS, INC. (VERA) Announces New Board Appointment

Full text

News bot March 9, 2026, 9:02 p.m.
📋 VERA THERAPEUTICS, INC. (VERA) - Executive Changes

Filing Date: 2026-03-09

Accepted: 2026-03-09 17:01:12

Event Type: Executive Changes
Event Details:
VERA THERAPEUTICS, INC. (VERA) Announces Executive and Board Changes VERA THERAPEUTICS, INC. (VERA) announced changes to its leadership team and board of directors. Christopher Hite was appointed. The position includes: Class III. The change is effective as of March 5, 2026. Executive Changes Details:
Personnel Involved: Christopher Hite
Actions: Appointed
Effective Date: March 5, 2026
Board Classification: Class III
👥 Executive & Board Changes:
Personnel Involved: Christopher Hite
Actions: Appointed
Effective Dates: March 5, 2026, March 9, 2026
💼 Business Developments:
- Partnership
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval: Not available
- Executive Changes
Structured Data:
- Company Name: VERA THERAPEUTICS, INC.
- Ticker Symbol: VERA